Covid-19: ICMR revised strategy for testing in country

On Monday, The Indian Council of Medical Research (ICMR) has revised the strategy for testing coronavirus disease as the number of infected people crossed 1,00,000 mark today
The updated strategy proposes all symptomatic individuals who have recent history of travel tp abroad in the past 14 days to be tested. The strategy also says that test would also be conducted on all symptomatic contacts of laboratory confirmed cases, healthcare workers who are in the battlefield against Covid-19 and patients suffering from Severe Acute Respiatory Infection or SARI.

According to new ICMR testing strategy says, the high-risk contacts of a confirmed case should be tested once between day 5 and day 10 of coming into contact. All symptomatic patients with Influenza Like Illness (ILI) and patients who develop ILI symptoms should also be tested.

Dr Rajnikant Srivastava, the head of the Department of Research Management, Policy Planning and Communication at ICMR said, Till Friday, a total of 20,39,952 samples were tested in the country with 92,911 tests being conducted since Thursday 9 am.

  • Related Posts

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    Patients for Patient Safety Foundation (PFPSF) Partners with CAHO to RollOut an Excellence Program New Delhi: Thanks to some well-meaning organizations, patients are going to be lord of all they…

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Three arrested after liquor bottles found at pharma firm

    Three arrested after liquor bottles found at pharma firm

    NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

    NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

    National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

    National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

    Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

    Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

    Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

    Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

    Gujarat FDCA cracks down on four firms for illegal drug sale; cancels licences of two

    Gujarat FDCA cracks down on four firms for illegal drug sale; cancels licences of two